Oviya MedSafe is a global Pharmacovigilance Consulting & Drug Safety Services company incorporated in India in 2012 and in the United Kingdom in 2014, offering advisory and outsourced support to the pharmaceutical industry. Oviya MedSafe is backed by 100 years of collective intelligence of its founding groups and works with renowned pharmaceutical companies and marketing authorization holders in various parts of the world. 

Oviya MedSafe provides end-to-end global drug safety support (combined with regulatory-compliant drug safety database access, as required) to pharmaceutical companies with mature pharmacovigilance systems. More importantly, Oviya MedSafe comprehensively consults to generic pharmaceutical companies across the globe to help them constantly evolve their pharmacovigilance departments to be in line with the regulations pertinent to their market presence.

Oviya MedSafe has brought together a panel of senior advisors and a robust team of pharmacovigilance professionals to build a formidable combination that provides high quality pharmacovigilance consulting and drug safety services to pharmaceutical companies, research organizations and health agencies – both governmental and non-governmental.
 
Our Board:

* Dr V Janarthanan, Eminent Surgeon & Head of the KTVR Vijaydeepa Group is the Chairman of Oviya MedSafe.

* Dr J Vijay Venkatraman, Diabetologist & Pharmacovigilance Physician is the Managing Director & CEO of Oviya MedSafe.

* Dr C J Arun Raja, Orthopaedic Surgeon with special interest in evidence-based medicine and research, is a Director.

KTVR Vijaydeepa Group and Ma Foi Strategic Consultants Pvt Ltd hold the shares of Oviya MedSafe Pvt Ltd, which was incorporated in India in 2012.

Oviya MedSafe UK Ltd, a wholly owned subsidiary of Oviya MedSafe Pvt Ltd, was incorporated in the United Kingdom in 2014.

Oviya MedSafe

Similar companies